Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

16 April 2021: Original Paper

Efficacy and Safety of Once-Daily LCP-Tacrolimus Versus Twice-Daily Immediate-Release Tacrolimus in Adult Hispanic Stable Kidney Transplant Recipients: Sub-Group Analysis from a Phase 3 Trial

Arman Faravardeh 1DE* , Sanjeev Akkina 2DE , Rafael Villicana 3DE , Giselle Guerra 4DE , Misbah A. Moten 5ADE , Ulf Meier-Kriesche 5ADE , Daniel R. Stevens 5ACDE , Samir J. Patel 5DE , Suphamai Bunnapradist 6DE

DOI: 10.12659/AOT.929535

Ann Transplant 2021; 26:e929535

Table 3 Fisher’s exact test was performed to compare the proportion of patients who either did or did not experience the adverse event.

Event, n (%)Switched to LCPTRemained on IR-Tac
N=26N=29
Urinary tract infection1 (4)2 (7)
Diarrhea1 (4)1 (3)
Blood creatinine increased1 (4)1 (3)
Anemia1 (4)0
Drug level increased1 (4)0
Dyspepsia1 (4)0
Hyperkalemia1 (4)0
Leukopenia1 (4)0
Nausea1 (4)0
Nephropathy toxic1 (4)0
Oral candidiasis01 (3)
Renal function test abnormal1 (4)0
Urosepsis01 (3)
Vomiting1 (4)0
IR-Tac – immediate-release tacrolimus; LCPT – LCP-tacrolimus.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358